Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Lenalidomide may stop the growth of solid tumors by blocking blood flow to the
tumor. Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways
to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving lenalidomide together with docetaxel and carboplatin may kill more tumor
cells.
PURPOSE: This phase I trial is studying the side effects and best dose of lenalidomide when
given together with docetaxel and carboplatin in treating patients with advanced solid
tumors.